Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki W Krakowie

At Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Uniwersytecki w Krakowie, the ophthalmology department is active in trials focused on diabetic macular edema, age-related macular degeneration, uveitic macular edema, and thyroid eye disease. These studies are designed to evaluate new treatments and compare them with current care, with the goal of improving vision and slowing disease progression.

• Testing new therapies for retinal and inflammatory eye conditions
• Evaluating treatments for vision loss in diabetic eye disease
• Studying options for thyroid eye disease and related orbital inflammation

The site’s strong eye-disease focus reflects its clinical specialization in both ophthalmology and ocular oncology.

Many trials at this hospital investigate cancers of the blood and solid tumors, including breast cancer, lymphoma, acute myeloid leukemia, multiple myeloma, prostate cancer, and gastrointestinal cancers. The research mainly aims to improve treatment effectiveness, extend survival, and find better options for patients with advanced or relapsed disease.

• Assessing novel combinations for breast cancer, including hormone receptor-positive and triple-negative disease
• Studying therapies for lymphoma, myelofibrosis, and other hematologic malignancies
• Evaluating treatment strategies for advanced gastrointestinal, liver, ovarian, and urothelial cancers

Overall, the oncology portfolio is broad and includes both targeted treatments and immune-based approaches across multiple cancer types.

Clinical research in cardiovascular diseases includes heart failure, atrial fibrillation, myocardial infarction, hypertension, and stroke prevention. Additional studies address diabetes mellitus, chronic kidney disease, and other metabolic problems, with a focus on better control of risk and prevention of serious complications.

• Testing approaches to reduce stroke risk in people with atrial fibrillation or after recent ischemic events
• Evaluating treatments for heart failure and blood pressure that remains difficult to control
• Studying therapies for type 2 diabetes and related metabolic disorders

These trials show a clear interest in preventing cardiovascular events while also addressing common chronic comorbidities.

The site also conducts research in neurological diseases and immune-mediated conditions, including multiple sclerosis, myasthenia gravis, epilepsy, autoimmune encephalitis, and amyotrophic lateral sclerosis. These studies are aimed at improving symptom control, reducing disease activity, and finding safer long-term treatment options.

• Exploring therapies for relapsing and progressive multiple sclerosis
• Evaluating treatments for myasthenia gravis and other neuromuscular disorders
• Studying seizure control in refractory epilepsy and emergency seizure conditions

This area combines neurology with immunology, reflecting a strong interest in disorders driven by immune dysfunction.

Research here extends to hormonal diseases, genetic conditions, and rare immune disorders such as congenital adrenal hyperplasia, hypoparathyroidism, hereditary angioedema, and Niemann-Pick disease type C1. The purpose of these trials is often to improve disease control, reduce symptoms, and better understand long-term safety and effectiveness of emerging therapies.

• Studying treatment options for rare endocrine disorders and calcium regulation problems
• Evaluating new approaches for hereditary angioedema and other complement-related diseases
• Investigating therapies for inherited metabolic and genetic diseases

These trials highlight the site’s involvement in specialized research for patients with uncommon and often complex conditions.